EBR SYSTEMS INC. - Announcements

Market Cap $369.1M Add to my watchlist

Healthcare Medical Devices

EBR Systems, Inc. is engaged in the treatment for patients suffering from cardiac rhythm... EBR Systems, Inc. is engaged in the treatment for patients suffering from cardiac rhythm diseases by providing physiological stimulation through endocardiac pacing. The Company is engaged in developing and commercializing Wireless Stimulation Endocardially (WiSE), an implantable, cardiac pacing device able to provide stimulation to endocardial (inside the heart) heart tissue for the correction of heart rhythm conditions without requiring the use of leads. WiSE offers leadless solutions for LV Pacing, including cardiac resynchronization therapy (CRT) and conduction system pacing (CSP). The Company also offers CRT devices through the CRM subsegment under the brand names, including Visionist X4 CRT-P, Valitude X4 (CRT-P), Momentum CRT-D, Resonate X4 CRT-D, and Vigilant X4 CRT-D, among others. The Company operates various subsidiaries, which include EBR Systems (AUST) Pty. Ltd. and EBR Systems (UK) Limited, which establish clinical trials in Australia and the United Kingdom, respectively.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

EBR	EBR submits NTAP Application	PRICE SENSITIVE	16/10/24	233.05KB	Share
EBR	FDA commences substantive review of EBR PMA application	PRICE SENSITIVE	30/09/24	214.76KB	Share
EBR	EBR Placement and Institutional Entitlement Offer Completed	PRICE SENSITIVE	20/09/24	228.41KB	Share
EBR	Capital Raising Investor Presentation	PRICE SENSITIVE	18/09/24	1.79MB	Share
EBR	EBR Systems announces a A$50m capital raising	PRICE SENSITIVE	18/09/24	255.47KB	Share
EBR	Trading Halt	PRICE SENSITIVE	18/09/24	216.7KB	Share
EBR	EBR submits final PMA module to the U.S. FDA	PRICE SENSITIVE	29/08/24	245.51KB	Share
EBR	EBR Half Year Results 2024 and Securityholder Update	PRICE SENSITIVE	27/08/24	221.81KB	Share
EBR	Appendix 4D and Half Year Report & Accounts	PRICE SENSITIVE	27/08/24	532.22KB	Share
EBR	Form 10 registration with the US SEC	PRICE SENSITIVE	30/07/24	2.81MB	Share
EBR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/07/24	494.8KB	Share
EBR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/04/24	508.42KB	Share
EBR	S&P DJI Announces March 2024 Quarterly Rebalance	PRICE SENSITIVE	01/03/24	120.24KB	Share
EBR	EBR Systems Financial Results for FY2023	PRICE SENSITIVE	28/02/24	216.5KB	Share
EBR	Appendix 4E and FY2023 Consolidated Financial Statements	PRICE SENSITIVE	28/02/24	724.68KB	Share
EBR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/01/24	504.97KB	Share
EBR	CEO Healthcare Conference Presentation	PRICE SENSITIVE	15/11/23	3.37MB	Share
EBR	Update on Submission of Final Module to FDA	PRICE SENSITIVE	15/11/23	226.98KB	Share
EBR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	23/10/23	514.96KB	Share
EBR	Positive Results from the SOLVE-CRT Randomised Sub-Study	PRICE SENSITIVE	04/09/23	2.71MB	Share
EBR	EBR Half Year Results 2023 and Securityholder Update	PRICE SENSITIVE	29/08/23	224.16KB	Share
EBR	Appendix 4D and Half Year Report & Accounts	PRICE SENSITIVE	29/08/23	723.24KB	Share
EBR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	25/07/23	514.07KB	Share
EBR	Completion of Security Purchase Plan	PRICE SENSITIVE	25/07/23	214.48KB	Share
EBR	Security Purchase Plan Opens	PRICE SENSITIVE	30/06/23	538.72KB	Share
EBR	Capital Raising Presentation	PRICE SENSITIVE	23/06/23	1.39MB	Share
EBR	EBR Systems announces a A$35m capital raising	PRICE SENSITIVE	23/06/23	255.17KB	Share
EBR	Trading Halt	PRICE SENSITIVE	22/06/23	225.82KB	Share
EBR	CEO Presentation on SOLVE-CRT Pivotal Trial Top-line Data	PRICE SENSITIVE	22/05/23	1.32MB	Share
EBR	EBR Reports Positive Results for its Pivotal SOLVE-CRT Trial	PRICE SENSITIVE	22/05/23	274.13KB	Share
EBR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/04/23	514.64KB	Share
EBR	EBR confirms no anticipated financial exposure to SVB	PRICE SENSITIVE	13/03/23	190.97KB	Share
EBR	EBR Systems Financial Results for FY2022	PRICE SENSITIVE	28/02/23	218.07KB	Share
EBR	Appendix 4E and FY2022 Consolidated Financial Statements	PRICE SENSITIVE	28/02/23	678.83KB	Share
EBR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/23	471.36KB	Share
EBR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/10/22	441.94KB	Share
EBR	Reinstatement to Official Quotation	PRICE SENSITIVE	21/10/22	86.23KB	Share
EBR	Shareholder and Investor Webinar Presentation	PRICE SENSITIVE	21/10/22	10.56MB	Share
EBR	EBR WISE Device Update	PRICE SENSITIVE	21/10/22	250.3KB	Share
EBR	Suspension from Quotation	PRICE SENSITIVE	14/10/22	554.17KB	Share
EBR	EBR Half Year Results 2022 and Securityholder Update	PRICE SENSITIVE	29/08/22	220.96KB	Share
EBR	Appendix 4D and Half Year Report & Accounts	PRICE SENSITIVE	29/08/22	516.97KB	Share
EBR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/07/22	478.07KB	Share
EBR	EBR Systems secures US$50m growth capital facility	PRICE SENSITIVE	01/07/22	224.63KB	Share
EBR	EBR completes interim enrolment in pivotal SOLVE trial	PRICE SENSITIVE	01/07/22	222.73KB	Share
EBR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/04/22	474.3KB	Share
EBR	CEO Investor Presentation	PRICE SENSITIVE	14/03/22	925.23KB	Share
EBR	Leadless Pacemakers included in SOLVE-CRT IDE Clinical Trial	PRICE SENSITIVE	14/03/22	240.86KB	Share
EBR	EBR Systems Financial Results for FY2021	PRICE SENSITIVE	25/02/22	211.83KB	Share
EBR	Appendix 4E and FY2021 Consolidated Financial Statements	PRICE SENSITIVE	25/02/22	539.29KB	Share
EBR	EBR Investor Presentation	PRICE SENSITIVE	02/02/22	1001.84KB	Share
EBR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	20/01/22	479.09KB	Share

EBR EBR submits NTAP Application
16/10/24	PRICE SENSITIVE	233.05KB	Share
EBR FDA commences substantive review of EBR PMA application
30/09/24	PRICE SENSITIVE	214.76KB	Share
EBR EBR Placement and Institutional Entitlement Offer Completed
20/09/24	PRICE SENSITIVE	228.41KB	Share
EBR Capital Raising Investor Presentation
18/09/24	PRICE SENSITIVE	1.79MB	Share
EBR EBR Systems announces a A$50m capital raising
18/09/24	PRICE SENSITIVE	255.47KB	Share
EBR Trading Halt
18/09/24	PRICE SENSITIVE	216.7KB	Share
EBR EBR submits final PMA module to the U.S. FDA
29/08/24	PRICE SENSITIVE	245.51KB	Share
EBR EBR Half Year Results 2024 and Securityholder Update
27/08/24	PRICE SENSITIVE	221.81KB	Share
EBR Appendix 4D and Half Year Report & Accounts
27/08/24	PRICE SENSITIVE	532.22KB	Share
EBR Form 10 registration with the US SEC
30/07/24	PRICE SENSITIVE	2.81MB	Share
EBR Quarterly Activities/Appendix 4C Cash Flow Report
26/07/24	PRICE SENSITIVE	494.8KB	Share
EBR Quarterly Activities/Appendix 4C Cash Flow Report
26/04/24	PRICE SENSITIVE	508.42KB	Share
EBR S&P DJI Announces March 2024 Quarterly Rebalance
01/03/24	PRICE SENSITIVE	120.24KB	Share
EBR EBR Systems Financial Results for FY2023
28/02/24	PRICE SENSITIVE	216.5KB	Share
EBR Appendix 4E and FY2023 Consolidated Financial Statements
28/02/24	PRICE SENSITIVE	724.68KB	Share
EBR Quarterly Activities/Appendix 4C Cash Flow Report
29/01/24	PRICE SENSITIVE	504.97KB	Share
EBR CEO Healthcare Conference Presentation
15/11/23	PRICE SENSITIVE	3.37MB	Share
EBR Update on Submission of Final Module to FDA
15/11/23	PRICE SENSITIVE	226.98KB	Share
EBR Quarterly Activities/Appendix 4C Cash Flow Report
23/10/23	PRICE SENSITIVE	514.96KB	Share
EBR Positive Results from the SOLVE-CRT Randomised Sub-Study
04/09/23	PRICE SENSITIVE	2.71MB	Share
EBR EBR Half Year Results 2023 and Securityholder Update
29/08/23	PRICE SENSITIVE	224.16KB	Share
EBR Appendix 4D and Half Year Report & Accounts
29/08/23	PRICE SENSITIVE	723.24KB	Share
EBR Quarterly Activities/Appendix 4C Cash Flow Report
25/07/23	PRICE SENSITIVE	514.07KB	Share
EBR Completion of Security Purchase Plan
25/07/23	PRICE SENSITIVE	214.48KB	Share
EBR Security Purchase Plan Opens
30/06/23	PRICE SENSITIVE	538.72KB	Share
EBR Capital Raising Presentation
23/06/23	PRICE SENSITIVE	1.39MB	Share
EBR EBR Systems announces a A$35m capital raising
23/06/23	PRICE SENSITIVE	255.17KB	Share
EBR Trading Halt
22/06/23	PRICE SENSITIVE	225.82KB	Share
EBR CEO Presentation on SOLVE-CRT Pivotal Trial Top-line Data
22/05/23	PRICE SENSITIVE	1.32MB	Share
EBR EBR Reports Positive Results for its Pivotal SOLVE-CRT Trial
22/05/23	PRICE SENSITIVE	274.13KB	Share
EBR Quarterly Activities/Appendix 4C Cash Flow Report
26/04/23	PRICE SENSITIVE	514.64KB	Share
EBR EBR confirms no anticipated financial exposure to SVB
13/03/23	PRICE SENSITIVE	190.97KB	Share
EBR EBR Systems Financial Results for FY2022
28/02/23	PRICE SENSITIVE	218.07KB	Share
EBR Appendix 4E and FY2022 Consolidated Financial Statements
28/02/23	PRICE SENSITIVE	678.83KB	Share
EBR Quarterly Activities/Appendix 4C Cash Flow Report
30/01/23	PRICE SENSITIVE	471.36KB	Share
EBR Quarterly Activities/Appendix 4C Cash Flow Report
26/10/22	PRICE SENSITIVE	441.94KB	Share
EBR Reinstatement to Official Quotation
21/10/22	PRICE SENSITIVE	86.23KB	Share
EBR Shareholder and Investor Webinar Presentation
21/10/22	PRICE SENSITIVE	10.56MB	Share
EBR EBR WISE Device Update
21/10/22	PRICE SENSITIVE	250.3KB	Share
EBR Suspension from Quotation
14/10/22	PRICE SENSITIVE	554.17KB	Share
EBR EBR Half Year Results 2022 and Securityholder Update
29/08/22	PRICE SENSITIVE	220.96KB	Share
EBR Appendix 4D and Half Year Report & Accounts
29/08/22	PRICE SENSITIVE	516.97KB	Share
EBR Quarterly Activities/Appendix 4C Cash Flow Report
27/07/22	PRICE SENSITIVE	478.07KB	Share
EBR EBR Systems secures US$50m growth capital facility
01/07/22	PRICE SENSITIVE	224.63KB	Share
EBR EBR completes interim enrolment in pivotal SOLVE trial
01/07/22	PRICE SENSITIVE	222.73KB	Share
EBR Quarterly Activities/Appendix 4C Cash Flow Report
27/04/22	PRICE SENSITIVE	474.3KB	Share
EBR CEO Investor Presentation
14/03/22	PRICE SENSITIVE	925.23KB	Share
EBR Leadless Pacemakers included in SOLVE-CRT IDE Clinical Trial
14/03/22	PRICE SENSITIVE	240.86KB	Share
EBR EBR Systems Financial Results for FY2021
25/02/22	PRICE SENSITIVE	211.83KB	Share
EBR Appendix 4E and FY2021 Consolidated Financial Statements
25/02/22	PRICE SENSITIVE	539.29KB	Share
EBR EBR Investor Presentation
02/02/22	PRICE SENSITIVE	1001.84KB	Share
EBR Quarterly Activities/Appendix 4C Cash Flow Report
20/01/22	PRICE SENSITIVE	479.09KB	Share

REFRESH

(20min delay)
Last $1.00		Change 0.000(0.00%)		Mkt cap ! $369.1M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	13162	97.5¢

Sellers (Offers)

Price($)	Vol.	No.
99.5¢	311	1

View Market Depth

No.	Vol.	Price($)
2	13162	0.975
3	12777	0.970
1	10000	0.960
3	13558	0.950
1	4500	0.945

Price($)	Vol.	No.
0.995	311	1
1.000	43015	1
1.005	10000	1
1.010	7000	2
1.020	11000	1

Last trade - 10.05am 05/11/2024 (20 minute delay)

EBR (ASX) Chart

Day chart unavailable

EBR SYSTEMS INC. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available